Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay.
Priyanka C IyerRamona DaduAnna BarqueCleslei ZanelliXingyu ZhengHuimin JiangP Sean WalshYangyang HaoJing HuangJoshua P KlopperRichard T KloosMaria CabanillasPublished in: The Journal of clinical endocrinology and metabolism (2024)
The analytical robustness and reproducibility of the Afirma TERT test support its routine clinical use among thyroid nodules with indeterminate cytology that are Afirma Genomic Sequencing Classifier suspicious or among Bethesda V/VI nodules.